Driving Advances in Liver Health: Tackling Current Challenges in Viral Hepatitis and NASH

In this video and accompanying downloadable slides, expert faculty discuss approaches to improve diagnosis and treatment of hepatitis C, hepatitis B, and NASH with an emphasis on how clinicians can maximize liver health.
Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH
Oluwaseun Falade-Nwulia, MBBS, MPH


No therapies are FDA approved for NASH, but I believe metabolic, inflammatory, and fibrotic aspects of NASH will all shape its management.

Manal F. Abdelmalek, MD, MPH Released: October 4, 2019

Why the path to HCV elimination must reach PWID.

Oluwaseun Falade-Nwulia, MBBS, MPH Released: October 14, 2019

We must stay the course to eliminate HBV as a public health threat.

Paul Y. Kwo, MD
Program Director
Released: October 16, 2019

How long should patients with chronic hepatitis B be treated with nucleos(t)ide analogues? When should we treat patients with immune-tolerant hepatitis B? Here’s my take.

Paul Y. Kwo, MD
Program Director
Released: December 4, 2019

How can providers ensure that vulnerable populations are linked to HCV testing and care? Here’s my take on what we should be doing in our practice.

Oluwaseun Falade-Nwulia, MBBS, MPH Released: December 18, 2019

Here’s my take on bariatric surgery, noninvasive testing, and endpoints in patients with NASH.

Manal F. Abdelmalek, MD, MPH Released: January 16, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?